| Cardiovascular Risk Management |
1 |
0.9 |
| Wisconsin |
0 |
0.56 |
| Rheumatoid Arthritis |
0 |
0.52 |
| Steroids |
0 |
0.47 |
| Arthritis |
0 |
0.37 |
| Michigan |
0 |
0.37 |
| Glucocorticoid |
0 |
0.28 |
| Acute Coronary Syndrome |
0 |
0.18 |
| Cerebrovascular Accident |
0 |
0.17 |
| Angina Pectoris |
0 |
0.14 |
| Myocardial Infarction (MI) |
0 |
0.14 |
| Patient Safety |
0 |
0.13 |
| Adverse Effects |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Bone |
0 |
0.09 |
| C-Reactive Protein (CRP) |
0 |
0.09 |
| Cardiovascular disease |
0 |
0.09 |
| Dyslipidemia |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Hyperglycemia |
0 |
0.09 |
| Infarction |
0 |
0.09 |
| Transient Ischemic Attack |
0 |
0.09 |
| Unstable Angina |
0 |
0.09 |
| Biologic Therapy |
0 |
0.08 |
| Lipids Management |
0 |
0.08 |
| Toxicology |
0 |
0.08 |